TScan Therapeutics, Inc 10-K for FY2022
TScan Therapeutics, Inc. (TCRX)
10-K
2023-03-08
For: 2022-12-31
View Original
Added on
April 06, 2026
About this 10-K
TScan Therapeutics, Inc filed this 10-K on March 8, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $13.54M
- up 33.5% from $10.14M a year earlier
- Net loss
- $66.22M
- compared with a net loss of $48.63M a year earlier
- Diluted EPS
- -$2.75
- compared with -$4.17 a year earlier